← 產業報告目錄
US Hemorrhoid Treatment Market Research Report Forecast to 2032
授權報價
| Single User Price | $2,950 USD |
| Multi User Licence (up to 10 users) | $3,950 USD |
| Enterprisewide Price (Global Site License) | $5,250 USD |
報告摘要
US Hemorrhoid Treatment Market Research Report Forecast to 2032
Market Overview
Hemorrhoids treatment refers to medical or surgical interventions aimed at relieving the discomfort and symptoms associated with hemorrhoids, which are swollen or inflamed blood vessels in the rectal or anal area. Treatment can include lifestyle modifications, over-the-counter remedies, minimally invasive procedures, or surgery, depending on the severity of the condition. The goal is to reduce pain, bleeding, itching, and inflammation while improving the patient's quality of life.
The US hemorrhoids treatment market is predicted to expand due to the increasing prevalence of hemorrhoids and growing aging population, and rapid advancements in technology, However, product recall and stringent regulations are limiting market expansion. rising demand in emerging markets on the other hand, boosts the market's attractiveness.
Market Segmentation
Based on the type, the US hemorrhoids treatment market has been segmented into internal hemorrhoids, external hemorrhoids, and prolapsed hemorrhoids.
Based on the treatment type, the market has been segmented into surgical and non-surgical.
Based on the specialist, the US hemorrhoids treatment market has been segmented into proctologist, general physician, and gastroenterologist.
Based on end user, market has been segmented into hospitals & clinics, ambulatory surgical centers, and others.
Major Players
The key players in the US Hemorrhoid Treatment market are Johnson & Johnson Services, Inc, Pfizer Inc., Abbott, Boston Scientific Corporation, Pfizer Inc, CONMED Corporation, Cook Medical, Medtronic Plc, Privi Medical.
目錄 Table of Contents
TABLE OF CONTENTS
1 MARKET INTRODUCTION 16
1.1 DEFINITION 16
1.2 SCOPE OF THE STUDY 16
1.3 RESEARCH OBJECTIVE 16
1.4 MARKET STRUCTURE 17
2 RESEARCH METHODOLOGY 18
2.1 OVERVIEW 18
2.2 DATA FLOW 20
2.2.1 Data Mining Process 20
2.3 PURCHASED DATABASE: 21
2.4 SECONDARY SOURCES: 22
2.4.1 Secondary Research data flow: 23
2.5 PRIMARY RESEARCH: 24
2.5.1 Primary Research DATA FLOW: 25
2.5.2 Primary Research: Number of Interviews conducted 26
2.6 APPROACHES FOR MARKET SIZE ESTIMATION: 27
2.6.1 Revenue Analysis Approach 27
2.7 DATA FORECASTING 27
2.7.1 Data forecasting Technique 28
2.8 DATA MODELING 29
2.8.1 microeconomic factor analysis: 29
2.8.2 Data modeling: 30
2.9 TEAMS AND ANALYST CONTRIBUTION 32
3 MARKET DYNAMICS 34
3.1 INTRODUCTION 34
3.2 DRIVERS 34
3.2.1 Increasing Prevalence of Hemorrhoids 34
3.2.2 Growing aging population 35
3.2.3 NEW APPROACHES TO TREAT HEMORRHOIDS 35
3.3 RESTRAINTS 36
3.3.1 Product Recall 36
3.4 OPPORTUNITY 38
3.4.1 INNOVATION IN HEMORRHOID TREATMENT DEVICES 38
4 MARKET FACTOR ANALYSIS 39
4.1 VALUE CHAIN ANALYSIS 39
4.1.1 R&D and Designing 40
4.1.2 Manufacturing 40
4.1.3 Distribution 40
4.1.4 Post-Sales Monitoring 40
4.2 PORTER’S FIVE FORCES MODEL 41
4.2.1 Threat of New Entrants 42
4.2.2 Bargaining Power of Suppliers 42
4.2.3 Threat of Substitutes 42
4.2.4 Bargaining Power of Buyers 42
4.2.5 Intensity of Rivalry 42
4.3 IMPACT OF COVID-19 ON THE US HEMORRHOIDS TREATMENT MARKET 42
4.3.1 impact on supply chain 42
4.3.2 impact on Pricing 43
4.3.3 impact on Research and Devlopment 43
5 US HEMORRHOIDS TREATMENT MARKET, BY TYPE 45
5.1 OVERVIEW 45
6 US HEMORRHOIDS TREATMENT MARKET, BY TREATMENT TYPE 47
6.1 OVERVIEW 47
7 US HEMORRHOIDS TREATMENT MARKET, BY SPECIALIST 50
7.1 OVERVIEW 50
8 US HEMORRHOIDS TREATMENT MARKET, BY END USER 52
8.1 OVERVIEW 52
9 COMPETITIVE LANDSCAPE 55
9.1 INTRODUCTION 55
9.2 MARKET SHARE ANALYSIS, 2022 55
9.3 COMPETITOR DASHBOARD 56
9.4 PUBLIC PLAYERS STOCK SUMMARY 57
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 57
10 COMPANY PROFILES 58
10.1 MEDTRONIC PLC 58
10.1.1 COMPANY OVERVIEW 58
10.1.2 FINANCIAL OVERVIEW 59
10.1.3 Products OFFERed 59
10.1.4 KEY DEVELOPMENTS 60
10.1.5 SWOT ANALYSIS 60
10.1.6 Key Strategy 60
10.2 CONMED CORPORATION 61
10.2.1 COMPANY OVERVIEW 61
10.2.2 FINANCIAL OVERVIEW 62
10.2.3 Products OFFERed 62
10.2.4 KEY DEVELOPMENTS 62
10.2.5 Key Strategy 63
10.3 COOK MEDICAL 64
10.3.1 COMPANY OVERVIEW 64
10.3.2 FINANCIAL OVERVIEW 64
10.3.3 PRODUCTS OFFERED 64
10.3.4 Key developments 65
10.3.5 SWOT ANALYSIS 65
10.3.6 KEY STRATEGIES 65
10.4 PFIZER, INC. 66
10.4.1 COMPANY OVERVIEW 66
10.4.2 FINANCIAL OVERVIEW 67
10.4.3 PRODUCTS OFFERED 67
10.4.4 Key developments 67
10.4.5 KEY STRATEGIES 68
10.5 JOHNSON & JOHNSON SERVICES, INC. 69
10.5.1 COMPANY OVERVIEW 69
10.5.2 FINANCIAL OVERVIEW 70
10.5.3 Products OFFERed 70
10.5.4 KEY DEVELOPMENTS 70
10.5.5 SWOT ANALYSIS 71
10.5.6 Key Strategy 71
10.6 ABBOTT 72
10.6.1 COMPANY OVERVIEW 72
10.6.2 FINANCIAL OVERVIEW 73
10.6.3 PRODUCTS OFFERED 73
10.6.4 KEY DEVELOPMENTS 74
10.6.5 SWOT ANALYSIS 74
10.6.6 KEY STRATEGIES 74
10.7 BOSTON SCIENTIFIC CORPORATION 75
10.7.1 COMPANY OVERVIEW 75
10.7.2 FINANCIAL OVERVIEW 76
10.7.3 PRODUCTS OFFERED 76
10.7.4 KEY DEVELOPMENTS 77
10.7.5 SWOT ANALYSIS 77
10.7.6 KEY STRATEGIES 77
10.8 INTEGRA LIFESCIENCES 78
10.8.1 COMPANY OVERVIEW 78
10.8.2 FINANCIAL OVERVIEW 79
10.8.3 PRODUCTS OFFERED 79
10.8.4 KEY DEVELOPMENTS 80
10.8.5 KEY STRATEGIES 80
10.9 SKLAR SURGICAL INSTRUMENTS 81
10.9.1 COMPANY OVERVIEW 81
10.9.2 FINANCIAL OVERVIEW 81
10.9.3 PRODUCTS OFFERED 81
10.9.4 KEY DEVELOPMENTS 82
10.9.5 KEY STRATEGIES 82
10.10 PRIVI MEDICAL PTE LTD 83
10.10.1 COMPANY OVERVIEW 83
10.10.2 FINANCIAL OVERVIEW 83
10.10.3 PRODUCTS OFFERED 83
10.10.4 KEY DEVELOPMENTS 84
10.10.5 KEY STRATEGIES 84
11 DATA CITATIONS 85
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 30
TABLE 2 US HEMORRHOIDS TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION) 46
TABLE 3 US HEMORRHOIDS TREATMENT MARKET, BY TREATMENT TYPE, 2019–2032 (USD MILLION) 48
TABLE 4 US HEMORRHOIDS TREATMENT MARKET, FOR SURGICAL, BY TYPE, 2019–2032 (USD MILLION) 48
TABLE 5 US HEMORRHOIDS TREATMENT MARKET, FOR NON-SURGICAL, BY TYPE, 2019–2032 (USD MILLION) 49
TABLE 6 US HEMORRHOIDS TREATMENT MARKET, FOR MEDICATION, BY MEDICATION CHANNEL TYPE, 2019–2032 (USD MILLION) 49
TABLE 7 US HEMORRHOIDS TREATMENT MARKET, FOR MEDICAL DEVICES, BY TYPE, 2019–2032 (USD MILLION) 49
TABLE 8 US HEMORRHOIDS TREATMENT MARKET, BY SPECIALIST, 2019–2032 (USD MILLION) 51
TABLE 9 US HEMORRHOIDS TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION) 53
TABLE 10 PUBLIC PLAYERS STOCK SUMMARY 57
TABLE 11 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 57
TABLE 12 MEDTRONIC PLC: PRODCUTS OFFERED 59
TABLE 13 CONMED CORPORATION: PRODUCTS OFFERED 62
TABLE 14 COOK MEDICAL: PRODUCTS OFFERED 64
TABLE 15 PFIZER, INC. : PRODUCTS OFFERED 67
TABLE 16 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 70
TABLE 17 ABBOTT: PRODUCTS OFFERED 73
TABLE 18 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 76
TABLE 19 INTEGRA LIFESCIENCES: PRODUCTS OFFERED 79
TABLE 20 SKLAR SURGICAL INSTRUMENTS: PRODUCTS OFFERED 81
TABLE 21 PRIVI MEDICAL: PRODCUTS OFFERED 83
LIST OF FIGURES
FIGURE 1 US HEMORRHOIDS TREATMENT MARKET: STRUCTURE 17
FIGURE 2 US HEMORRHOIDS TREATMENT MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 34
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 36
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 37
FIGURE 5 VALUE CHAIN ANALYSIS OF THE US HEMORRHOIDS TREATMENT MARKET 39
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: US HEMORRHOIDS TREATMENT MARKET 41
FIGURE 7 US HEMORRHOIDS TREATMENT MARKET, TYPE SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 45
FIGURE 8 US HEMORRHOIDS TREATMENT MARKET SHARE, BY TYPE, 2022 (%) 45
FIGURE 9 US HEMORRHOIDS TREATMENT MARKET, BY TYPE, 2022 & 2032 (USD MILLION) 46
FIGURE 10 US HEMORRHOIDS TREATMENT MARKET, TREATMENT TYPE SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 47
FIGURE 11 US HEMORRHOIDS TREATMENT MARKET SHARE, BY TREATMENT TYPE, 2022 (%) 47
FIGURE 12 US HEMORRHOIDS TREATMENT MARKET, BY TREATMENT TYPE, 2022 & 2032 (USD MILLION) 48
FIGURE 13 US HEMORRHOIDS TREATMENT MARKET, SPECIALIST SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 50
FIGURE 14 US HEMORRHOIDS TREATMENT MARKET SHARE, BY SPECIALIST, 2022 (%) 50
FIGURE 15 US HEMORRHOIDS TREATMENT MARKET, BY SPECIALIST, 2022 & 2032 (USD MILLION) 51
FIGURE 16 US HEMORRHOIDS TREATMENT MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 52
FIGURE 17 US HEMORRHOIDS TREATMENT MARKET SHARE, BY END USER, 2022 (%) 53
FIGURE 18 US HEMORRHOIDS TREATMENT MARKET, BY END USER, 2022 & 2032 (USD MILLION) 53
FIGURE 19 US HEMORRHOIDS TREATMENT MARKET PLAYERS: COMPETITIVE ANALSIS, 2022 55
FIGURE 20 COMPETITOR DASHBOARD: US HEMORRHOIDS TREATMENT MARKET 56
FIGURE 21 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT 59
FIGURE 22 MEDTRONIC PLC: SWOT ANALYSIS 60
FIGURE 23 CONMED CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 62
FIGURE 24 COOK MEDICAL: SWOT ANALYSIS 65
FIGURE 25 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT 67
FIGURE 26 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT 70
FIGURE 27 JOHNSON & JOHNSON SERVICES, INC.: SWOT ANALYSIS 71
FIGURE 28 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 73
FIGURE 29 ABBOTT: SWOT ANALYSIS 74
FIGURE 30 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 76
FIGURE 31 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 77
FIGURE 32 INTEGRA LIFESCIENCES: FINANCIAL OVERVIEW SNAPSHOT 79
提及公司
Johnson & Johnson ServicesIncPfizer Inc.AbbottBoston Scientific CorporationPfizer IncCONMED CorporationCook MedicalMedtronic PlcPrivi Medical
同分類最新報告（醫療與生命科學）
查看醫療與生命科學全部報告 →
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們